4.7 Article

Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings

期刊

LANCET INFECTIOUS DISEASES
卷 8, 期 8, 页码 516-523

出版社

ELSEVIER SCI LTD
DOI: 10.1016/S1473-3099(08)70184-1

关键词

-

资金

  1. Medical Research Council [MC_U117588499] Funding Source: researchfish
  2. MRC [MC_U117588499] Funding Source: UKRI
  3. Medical Research Council [MC_U117588499] Funding Source: Medline
  4. Wellcome Trust [072070] Funding Source: Medline

向作者/读者索取更多资源

The immune reconstitution inflammatory syndrome (IRIS) has emerged as an important early complication of antiretroviral therapy (ART) in resource-limited settings, especially in patients with tuberculosis. However, there are no consensus case definitions for IRIS or tuberculosis-associated IRIS. Moreover, previously proposed case definitions are not readily applicable in settings where laboratory resources are limited. As a result, existing studies on tuberculosis-associated IRIS have used a variety of non-standardised general case definitions. To rectify this problem, around 100 researchers, including microbiologists, immunologists, clinicians, epidemiologists, clinical trialists, and public-health specialists from 16 countries met in Kampala, Uganda, in November, 2006. At this meeting, consensus case definitions for paradoxical tuberculosis-associated IRIS, ART-associated tuberculosis, and unmasking tuberculosis-associated IRIS were derived, which can be used in high-income and resource-limited settings. It is envisaged that these definitions could be used by clinicians and researchers in a variety of settings to promote standardisation and comparability of data.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Immunology

Cognitive Impairment in Tuberculous Meningitis

Angharad G. Davis, Anna J. Dreyer, Christine Albertyn, Mpumi Maxebengula, Cari Stek, Sean Wasserman, Suzaan Marais, Kathleen Bateman, Mark Solms, John Joska, Robert J. Wilkinson, Sam Nightingale

Summary: This study systematically assessed the frequency and nature of cognitive impairment in adult tuberculous meningitis patients and found that it has an impact on functioning and medication adherence.

CLINICAL INFECTIOUS DISEASES (2023)

Article Immunology

Focused investigations to expedite cancer diagnosis among patients with lymphadenopathy in a tuberculosis and HIV-endemic region

Katherine Antel, Jenna Oosthuizen, Karryn Brown, Francois Malherbe, Perry Loebenberg, Cylene Seaton, Siphiwe Baloyi, Kudakwashe Simba, Dharshnee Chetty, Vernon J. Louw, Gary Maartens, Estelle R. Verburgh

Summary: In TB-endemic areas, lymphadenopathy caused by tuberculosis (TB) adenitis is common, but lymphoma and cancers are important differential diagnoses and need to be diagnosed early. The main obstacles to diagnosing lymphoma include empiric TB treatment and difficulty obtaining a biopsy. This study reports on a specialized clinic that uses high-yield investigations for patients with lymphadenopathy.
Article Pharmacology & Pharmacy

Drug-drug interaction between rifabutin and dolutegravir: A population pharmacokinetic model

Aida N. N. Kawuma, Roeland E. E. Wasmann, Kelly E. E. Dooley, Gary Maartens, Paolo Denti

Summary: Rifabutin may serve as an alternative to rifampicin in co-administration with dolutegravir, as it does not require dose adjustment and can achieve the desired drug concentration.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2023)

Article Pharmacology & Pharmacy

Analysis of serum microRNA-122 in a randomized controlled trial of N-acetylcysteine for treatment of antituberculosis drug-induced liver injury

Muhammed Shiraz Moosa, Giusy Russomanno, Jeffrey R. Dorfman, Hannah Gunter, Chandni Patel, Eithne Costello, Dan Carr, Gary Maartens, Munir Pirmohamed, Christopher Goldring, Karen Cohen

Summary: This study investigated the concentrations of miR-122 in participants with antituberculosis drug-induced liver injury (AT-DILI) and its correlation with alanine aminotransferase (ALT) concentrations. The study found that miR-122 concentrations in AT-DILI patients were significantly higher than those in healthy volunteers and in patients on antituberculosis therapy without liver injury, and N-acetylcysteine (NAC) had no effect on miR-122 concentrations.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2023)

Article Immunology

Initial Supplementary Dose of Dolutegravir in Second-Line Antiretroviral Therapy: A Noncomparative, Double-Blind, Randomized Placebo-Controlled Trial

Ying Zhao, Rulan Griesel, Zaayid Omar, Bryony Simmons, Andrew Hill, Gert van Zyl, Claire Keene, Gary Maartens, Graeme Meintjes

Summary: This study evaluated the need for an initial dolutegravir dose adjustment in adults switching from first-line TEE treatment to TLD. The results showed that in patients with unsuppressed HIV-1 RNA levels and substantial baseline resistance to nucleoside reverse transcriptase inhibitors, a high proportion achieved virologic suppression without the need for an initial dolutegravir dose adjustment.

CLINICAL INFECTIOUS DISEASES (2023)

Article Behavioral Sciences

Impact of COVID-19 on the well-being of children with epilepsy including nodding syndrome in Uganda: A qualitative study

Denis Nono, Nolbert Gumisiriza, Christopher Tumwine, Luis-Jorge Amaral, Herbert Elvis Ainamani, Seggane Musisi, Robert Colebunders

Summary: This study investigated the impact of the COVID-19 pandemic on the access and use of health services by children with epilepsy in Uganda. The study found that COVID-19-related restrictions created challenges for children with epilepsy, their parents, and healthcare providers, including reduced access to healthcare services, food insecurity, and inability to afford essential medicines. However, several coping strategies, such as parents engaging in casual work and healthcare workers intensifying outreach services, were adopted to address these challenges.

EPILEPSY & BEHAVIOR (2023)

Editorial Material Behavioral Sciences

How to decrease the epilepsy disease burden in sub-Saharan Africa?

Van Cutsem Gilles, Colebunders Robert

EPILEPSY & BEHAVIOR (2023)

Article Multidisciplinary Sciences

Effects of tuberculosis and/or HIV-1 infection on COVID-19 presentation and immune response in Africa

Elsa du Bruyn, Cari Stek, Remi Daroowala, Qonita Said-Hartley, Marvin Hsiao, Georgia Schafer, Rene S. Goliath, Fatima Abrahams, Amanda Jackson, Sean Wasserman, Brian Allwood, Angharad Davis, Rachel P. -J. Lai, Anna Coussens, Katalin A. Wilkinson, Jantina J. de Vries, Nicki Tiffin, Maddalena Cerrone, Ntobeko A. B. J. Ntusi, Catherine Riou, Robert Wilkinson

Summary: The study investigates the outcomes of SARS-CoV-2 infection in an African setting with high HIV-1 and tuberculosis prevalence. It finds that tuberculosis is a common comorbidity in hospitalized patients with COVID-19 and that the immune response to SARS-CoV-2 is negatively affected by the coexistence of HIV-1 and tuberculosis. This highlights the importance of considering these comorbidities in the management of COVID-19 in high-incidence settings.

NATURE COMMUNICATIONS (2023)

Correction Nanoscience & Nanotechnology

Nanostars Carrying Multifunctional Neurotrophic Dendrimers Protect Neurons in Preclinical In Vitro Models of Neurodegenerative Disorders (vol 14, pg 47445, 2022)

Corinne Morfill, Stanislava Pankratova, Pedro Machado, Nathalie K. Fernando, Anna Regoutz, Federica Talamona, Alessandra Pinna, Michal Klosowski, Robert J. Wilkinson, Roland A. Fleck, Fang Xie, Alexandra E. Porter, Darya Kiryushko

ACS APPLIED MATERIALS & INTERFACES (2023)

Article Immunology

Blood and Site of Disease Inflammatory Profiles Differ in Patients With Pericardial Tuberculosis and Human Immunodeficiency Virus Type 1

Hygon Mutavhatsindi, Elsa Du Bruyn, Sheena Ruzive, Patrick Howlett, Maddalena Cerrone, Alan Sher, Katrin D. Mayer-Barber, Daniel L. Barber, Mpiko Ntsekhe, Robert J. Wilkinson, Catherine Riou

Summary: This study investigated the systemic inflammatory profile in individuals with HIV-1 and latent TB infection (LTBI), pulmonary TB (PTB), or pericardial TB (PCTB). The results showed that most analytes were elevated at the site of infection (pericardial fluid) compared to blood. Additionally, HLA-DR expression was identified as a potential biomarker for TB diagnosis.

OPEN FORUM INFECTIOUS DISEASES (2023)

Article Behavioral Sciences

Quality of life of persons with epilepsy in Mahenge, an onchocerciasis-endemic area in Tanzania: A cross-sectional study

Luis-Jorge Amaral, Dan Bhwana, Messaline F. Fomo, Bruno P. Mmbando, Carmen-Nabintu Chigoho, Robert Colebunders

Summary: This study examined the quality of life of adults with epilepsy in an onchocerciasis-endemic area in Tanzania. The findings revealed that individuals with epilepsy in this region have a lower quality of life, highlighting the need to improve medication regimens and education levels.

EPILEPSY & BEHAVIOR (2023)

Review Immunology

Immune interaction between SARS-CoV-2 and Mycobacterium tuberculosis

Petro Booysen, Katalin A. Wilkinson, Dylan Sheerin, Robyn Waters, Anna K. Coussens, Robert J. Wilkinson

Summary: SARS-CoV-2 and Mycobacterium tuberculosis are major infectious causes of death, and co-infected patients have increased mortality rates. The immune interaction between these two pathogens impacts the outcomes of co-infected individuals. Both SARS-CoV-2 and Mtb modulate immune responses in cells such as monocytes, macrophages, neutrophils, and T cells.

FRONTIERS IN IMMUNOLOGY (2023)

Article Immunology

Relationship Between LTA4H Promotor Polymorphism and Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome and Its Prevention With Prednisone

Cari Stek, Muki Shey, Khuthala Mnika, Charlotte Schutz, Friedrich Thienemann, Robert J. Wilkinson, Lutgarde Lynen, Graeme Meintjes

Summary: The relationship between the LTA4H genotype and the development of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome (TB-IRIS) and the efficacy of prednisone in preventing TB-IRIS were investigated in a clinical trial. However, no association was found between the LTA4H genotype and the incidence of TB-IRIS or the efficacy of prednisone.

OPEN FORUM INFECTIOUS DISEASES (2023)

Article Microbiology

BACH1 promotes tissue necrosis and Mycobacterium tuberculosis susceptibility

Eduardo P. Amaral, Sivaranjani Namasivayam, Artur T. L. Queiroz, Eduardo Fukutani, Kerry L. Hilligan, Kate Aberman, Logan Fisher, Caio Cesar B. Bomfim, Keith Kauffman, Jay Buchanan, Leslie Santuo, Pedro Henrique Gazzinelli-Guimaraes, Diego L. Costa, Mariane Araujo Teixeira, Beatriz Barreto-Duarte, Clarissa Gurgel Rocha, Monique Freire Santana, Marcelo Cordeiro-Santos, Daniel L. Barber, Robert J. Wilkinson, Igor Kramnik, Kazuhiko Igarashi, Thomas Scriba, Katrin D. Mayer-Barber, Bruno B. Andrade, Alan Sher

Summary: The transcription factor Bach1 plays a key role in regulating host resistance to Mycobacterium tuberculosis infection by influencing antioxidant gene expression, inhibiting lipid peroxidation, and reducing necrosis and bacterial loads in mice. Its deletion increases resistance to Mtb-induced cell death and improves survival, highlighting Bach1 as a crucial regulator of cellular and tissue necrosis in Mtb infection.

NATURE MICROBIOLOGY (2023)

暂无数据